BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mcdowell L, Yom SS. Locally advanced non-melanomatous skin cancer: Contemporary radiotherapeutic management. Oral Oncology 2019;99:104443. [DOI: 10.1016/j.oraloncology.2019.104443] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Reddy P, Yao M, Patel M. Investigative Landscape in Advanced Non-Melanoma Skin Cancers. Curr Treat Options Oncol 2021;22:56. [PMID: 34097150 DOI: 10.1007/s11864-021-00853-0] [Reference Citation Analysis]
2 Pichi B, Moretto S, Petruzzi G, Zocchi J, Mazzola F, Manciocco V, Marchesi P, Pellini R. Surgeons reaching satisfying outcomes without surgery: nasal dorsum skin cancer recurrence treated with electrochemotherapy. Anticancer Drugs 2020;31:751-3. [PMID: 32697469 DOI: 10.1097/CAD.0000000000000946] [Reference Citation Analysis]
3 Choi KY, Schmalbach CE. Cutaneous Head and Neck Cancers in the High-Risk Immunosuppressed Population. Otolaryngol Clin North Am 2021;54:397-413. [PMID: 33602516 DOI: 10.1016/j.otc.2020.11.012] [Reference Citation Analysis]
4 Chen A, Santana AL, Doudican N, Roudiani N, Laursen K, Therrien JP, Lee J, Felsen D, Carucci JA. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLoS One 2020;15:e0241551. [PMID: 33227008 DOI: 10.1371/journal.pone.0241551] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Peters M, Smith JD, Kovatch KJ, McLean S, Durham AB, Basura G. Treatment and Outcomes for Cutaneous Periauricular Basal Cell Carcinoma: A 16-Year Institutional Experience. OTO Open 2020;4:2473974X20964735. [PMID: 33150296 DOI: 10.1177/2473974X20964735] [Cited by in F6Publishing: 1] [Reference Citation Analysis]